The Phase III ADAURA trial showed treatment with Tagrisso after surgery with curative intent the the risk of disease recurrence or death by around 80% More: Tagrisso shows 'unprecedented' disease free survival in lung cancer Source: News
read moreThe adjuvant could reduce the amount of vaccine protein required per dose and enhance the immune response More: GSK to make 1bn doses of pandemic vaccine adjuvant Source: News
read moreThe treatment for pancreatic inflammation has been shown in the lab to prevent COVID-19 from entering human cells More: CRUK, Latus and Edinburgh Uni launch test camostat for COVID-19 Source: News
read moreThe trial will test the potential of combining an antiviral with an immune modulator More: Roche begins trial of Actemra/RoActemra plus remdesivir Source: News
read moreThe ‘game-changing’ results will likely result in a paradigm shift in current clinical practice, researchers said More: MSD's Keytruda doubles PFS in bowel cancer subset Source: News
read moreASCO: Pfizer, Merck KGaA’s Bavencio lines up for bladder cancer edge with survival win chelfand Thu, 05/28/2020 – 12:29 More: ASCO: Pfizer, Merck KGaA's Bavencio lines up for bladder cancer edge with survival win Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals